HPTN Publications

Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum C, Buchbinder S, Koblin B, Seage G . Homozygous and Heterozygous CCR5-32 Genotypes are Associated with Resistence to HIV infection. J Acquir Immune Defic Syndr. 2001, 27: 472-81
Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB . Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 1999, 354: 803-9
Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB . The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa. Ann N Y Acad Sci. 2000, 918: 53-6
Marzinke M, Breaud A, Parsons TL, Cohen MS, Piwowar-Manning E, Eshleman SH, Clarke W . The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood. Clin Chim Acta. 2014, 10: 157-68
Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, Wheeler DP, Koblin BA, Eshleman SH, Fogel JM . Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clin Infect Dis. 2014, 58: 117-20
Masek BJ, Arora N, Quinn N, Aumakhan B, Holden J, Hardick A, Agreda P, Barnes M, Gaydos CA . Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. J Clin Microbiol. 2009, 47: 1663-7 PMCID: 2691063
Masemola A, Mashishi T, Khoury G, Mohube P, Mokgotho P, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM; HIVNET 028 Study Team . Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol. 2004, 78: 3233-43
Masemola AM, Mashishi TN, Khoury G, Bredell H, Paximadis M, Mathebula T, Barkhan D, Puren A, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM; HIVNET 028 Study Team . Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J Immunol. 2004, 173: 4607-17
Mastro TD, Kim AA, Hallett T, Rehle T, Welte A, Laeyendecker O, Oluoch T, Garcia-Calleja JM . Estimating HIV incidence in populations Using tests for recent Infection: Issues, challenges and the way forward. J HIV/AIDS Surv & Epidemiol. 2010, 2: 1-14 PMCID: 3130510
Mauck C, Rosenberg Z, Van Damme L . Recommendations for the clinical development of topical microbicides: an update. AIDS. 2001, 15: 857-68
Mayer K, Karim S, Kelly C, Maslankowski L, Rees H, Profy A, Day J, Welch J, Rosenberg Z . Safety and tolerability of vaginal PRO2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS. 2003, 17: 321-9
Mayer K, Peipert J, Fleming T, Fullem A, Moench T, Cu-Uvin S, Bentley M, Chesney M, Rosenberg Z . Safety and tolerability of Buffergel, a novel vaginal microbicide, in women in the United States. Clin Infect Dis. 2001, 32: 476-82
Mayer KH, Kwong J, Singall R, Boswell S . Non-occupational post-exposure prophylaxis: Clinical issues and public health questions. Medicine and Health/Rhode Island. 2000, 83: 210-3
Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, Masse B, Eshleman SH, Hendrix C, Morrow K, Rooney JF, Soto-Torres L; HPTN 050 Protocol Team . Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS. 2006, 20: 543-51 PMID: 16470118
Mayer KH, Pizer HF . HIV Prevention: A Comprehensive Approach. London Academic Press. 2008, ISBN: 0123742358
Mayer KH, Venkatesh KK . Antiretroviral therapy as HIV prevention: status and prospects. Am J Public Health. 2010, 100: 1867-76 PMCID: 2936983
Mayer KH, Wang L, Koblin B, Mannheimer S, Magnus M, del Rio C, Buchbinder S, Wilton L, Cummings V, Watson CC, Piwowar-Manning E, Gaydos C, Eshleman SH, Clarke W, Liu TY, Mao C, Griffith S, Wheeler D; HPTN061 Protocol Team, Wheeler D, HPTN 061 Protocol Team . Concomitant socioeconomic, behavioral, and biological factors associated with the disproportionate HIV infection burden among Black men who have sex with men in 6 U.S. cities. PLoS One. 2014, 9: e87298 PMCID: 3909083
Mayer KH, Wheeler DP, Bekker LG, Grinsztejn B, Remien RH, Sandfort TG, Beyrer C . Overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease HIV transmission in men who have sex with men. J Acquir Immune Defic Syndr. 2013, 63: S161-7 PMCID: 3740716
McConnell MS, Stringer JS, Kourtis AP, Weidle PJ, and Eshleman SH . Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?. Am J Obstet Gynecol. 2007, 197: S56-S63 PMID: 17825651
McFarland W, Gwanzura L, Bassett MT, Machekano R, Latif AS, Le C, Parsonnet J, Burke RL, Katzenstein D . Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis. 1999, 180: 1459-65
McFarland W, Mvere D, Shamu R, Katzenstein D . Risk factors for HIV infection among first-time blood donors in Zimbabwe. Transfusion. 1998, 38: 279-84
McGowan I, Elliott J, Cortina G, Tanner K, Siboliban C, Adler A, Cho D, Boscardin WJ, Soto-Torres L, Anton PA . Characterization of baseline intestinal mucosal indices of injury and inflammation in men for use in rectal microbicide trials (HIV Prevention Trials Network-056). J Acquir Immune Defic Syndr. 2007, 46: 417-25 PMID: 17891044
McGowan I, Wilkin T, Landovitz RJ, Wu C, Chen Y, Marzinke MA, Hendrix CW, Richardson P, Eshleman SH, Andrade A, Chege W, Anderson PL, McCauley M, Farley J, Mayer KH, Anton P, Brand RM, Cranston RD, Gulick R . The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM. AIDS. 2019, 33: 237-246
McKinstry LA, Zerbe A, Farrior J, Kurth AE, Stanton J, Li M, Elion R, Leider J, Branson B, El-Sadr WM, Hanscom B, for the HPTN 065 Study . A Randomized-Controlled Trial of Computer-based Prevention Counseling for HIV-Positive Persons (HPTN 065). 2017
Meany DL, Clarke W . Opiate DAU screening using dried urine specimens. Clin Chim Acta. 2009, 401: 188-189 PMCID:2634819
Mehendale SM, Ghate MV, Kishore Kumar B, Sahay S, Gamble TR, Godbole SV, Thakar MR, Kulkarni SS, Gupta A, Gangakhedkar RR, Divekar AD, Risbud AR, Paranjape RS, Bollinger RC . Low HIV-1 Incidence among Married Serodiscordant Couples in Pune, India. J Acquir Immune Defic Syndr. 2006, 41: 371-373 PMID: 16540940
Mehendale SM, Shepherd ME, Brookmeyer RS, Semba RD, Divekar AD, Gangakhedkar RR, Joshi S, Risbud AR, Paranjape RS, Gadkari DA, Bollinger RC . Low carotenoid concentration and the risk of HIV seroconversion in Pune, India. J Acquir Immune Defic Syndr. 2001, 26: 352-9
Mehta S, Manji KP, Young AM, Brown ER, Chasela C, Taha TE, Read JS, Goldenberg RL, Fawzi WW . Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women. Am J Clin Nutr. 2008, 87: 1639-49 PMCID:2474657
Metzger DS, Donnell D, Celentano DD, Jackson JB, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM, Chawarski M, Ruan Y, Richardson P, Shin K, Chen RY, Sugarman J, Dye BJ, Rose SM, Beauchamp G, Burns DN; HPTN 058 Protocol Team, Burns DN, HPTN 058 Protocol Team . Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine-Naloxone: HIV Prevention Trials Network 058. JAIDS. 2015, 68: 554-61
Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S, Gross M, Sheon A, Miller H, Cooley P, Seage GR 3rd . Randomized controlled trial of audio computer-assisted self- interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000, 152: 99-106
Miller WC, Hoffman IF, Hanscom BS, Ha TV, Dumchev K, Djoerban Z, Rose SM, Latkin CA, Metzger DS, Lancaster KE, Go VF, Dvoriak S, Mollan KR, Reifeis SA, Piwowar-Manning E, Richardson P, Hudgens MG, Hamilton EL, Sugarman J, Eshleman SH, Susami H, Chu VA, Djauzi S, Kiriazova T, Bui DD, Strathdee SA, Burns DN . A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study. Lancet. 2018, 392: 747-759
Mimiaga MJ, Noonan E, Donnell D, Safren SA, Koenen KC, Gortmaker S, O'Cleirigh C, Chesney MA, Coates TJ, Koblin BA, Mayer KH . Childhood sexual abuse is highly associated with HIV risk-taking behavior and infection among MSM in the EXPLORE Study. J Acquir Immune Defic Syndr. 2009, 51: 340-8 PMCID: 3292283
Mimiaga MJ, Safren SA, Benet DJ, Manseau MW, DeSousa N, Mayer KH . MSM in HIV-prevention trials are sexual partners with each other: An ancillary study to the EXPLORE intervention. AIDS Behav. 2006, 10: 27-34 PMID: 16331532
Mindry D, Maman S, Chirowodza A, Muravha T, van Rooyen H, Coates T . Looking to the future: South African men and women negotiating HIV risk and relationship intimacy. Cult Health Sex. 2011, 13: 589-602 PMCID: 3071520
Miotti, Taha, Kumwenda, Broadhead, Mtimavalye, Hoeven, Chiphangwi, Liomba, Biggar, Miotti PG, Taha TE, Kumwenda NI, Broadhead R, Mtimavalye LA, Van der Hoeven L, Chiphangwi JD, Liomba G, Biggar RJ . HIV transmission from breastfeeding: a study from Malawi. JAMA. 1999, 282: 744-9
Mirochnick M, Nielsen-Saines K, Pilotto JH, Pinto J, Jiménez E, Veloso VG, Parsons T, Watts DH, Moye J, Mofenson LM, Camarca M, Bryson Y; NICHD/HPTN 040/PACTG 1043 Protocol Team . Nevirapine concentrations in newborns receiving an extended prophylactic regimen. J Acquir Immune Defic Syndr. 2008, 47: 334-7 PMID:18398973
Mirochnick M, Nielsen-Saines K, Pilotto JH, Pinto J, Veloso VG, Rossi S, Moye J, Bryson Y, Mofenson L, Camarca M, Watts DH; NICHD HPTN 040/PACTG 1043 Protocol Team . Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life. Pediatr Infect Dis J. 2011, 30: 769-72 PMCID: 3158246
Mirochnick M, Taha T, Kreitchmann R, Nielsen-Saines K, Kumwenda N, Joao E, Pinto J, Santos B, Parsons T, Kearney B, Emel L, Herron C, Richardson P, Hudelson SE, Eshleman SH, George K, Fowler MG, Sato P, Mofenson L; HPTN 057 Protocol Team . Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life. J Acquir Immune Defic Syndr. 2014, 65: 33-41
Mitchell KM, Dimitrov D, Hughes JP, Xia F, Donnell D, Amico KR, Bokoch K, Chitwarakorn A, Bekker LG, Holtz TH, Mannheimer S, Grant RM, Boily MC . In what circumstances could non-daily pre-exposure prophylaxis for HIV substantially reduce program costs?. AIDS. 2018, 32: 809-818
Mitchla Z, Sharland M . Current treatment options to prevent perinatal transmission of HIV. Expert Opin Pharmacother. 2000, 1: 239-48
Mmiro FA, Aizire J, Mwatha AK, Eshleman SH, Donnell D, Fowler MG, Nakabiito C, Musoke P, Jackson JB, Guay LA . Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda. J Acquir Immune Defic Syndr. 2009, 52: 32-9 PMCID: 2767188
Momplaisir, F., Hussein, M., Tobin-Fiore, D., Smith, L., Bennett, D., Latkin, C., Metzger, D. S. . Racial Inequities in HIV Prevalence and Composition of Risk Networks Among People Who Inject Drugs in HIV Prevention Trial Network 037. J Acquir Immune Defic Syndr. 2018, 76: 394-401
Montgomery BE, Rompalo A, Hughes J, Wang J, Haley D, Soto-Torres L, Chege W, Justman J, Kuo I, Golin C, Frew P, Mannheimer S, Hodder S . Violence Against Women in Selected Areas of the United States. Am J Public Health. 2015, 105: 2156-66
Moon MW, Khumalo-Sakutukwa GN, Heiman JE, Mbizvo MT, Padian NS . Vaginal microbicides for HIV/STI prevention in Zimbabwe: what key informants say. J Transcult Nurs. 2002, 13: 19-23
Morin SF, Khumalo-Sakutukwa G, Charlebois ED, Routh J, Fritz K, Lane T, Vaki T, Fiamma A, Coates TJ . Removing barriers to knowing HIV status: same-day mobile HIV testing in Zimbabwe. JAIDS. 2006, 41: 218-24 PMID: 16394855
Morin SF, Maiorana A, Koester KA, Sheon NM, Richards A . Community Consultation in HIV Prevention Research: A Study of Community Advisory Boards at 6 Research Sites. J Acquir Immune Defic Syndr. 2003, 33: 513-20
Morin SF, Morfit S, Maiorana A, Aramrattana A, Goicochea P, Mutsambi JM, Robbins JL, Richards TA . Building community partnerships: case studies of Community Advisory Boards at research sites in Peru, Zimbabwe, and Thailand. Clin Trials. 2008, 5: 147-56 PMID:18375653
Morris SR, Klausner JD, Buchbinder SP, Wheeler SL, Koblin B, Coates T, Chesney M, Colfax GN . Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis. 2006, 43: 1284-9 PMID: 17051493
Morrow K, Rosen R, Richter L, Emans A, Forbes A, Day J, Morar N, Maslankowski L, Profy AT, Kelly C, Abdool Karim SS, Mayer KH . The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial. J Womens Health. 2003, 12: 655-66
Mracna M, Becker-Pergola G, Dileanis J, Guay LA, Cunningham S, Jackson JB, and Eshleman SH . Performance of the Applied Biosystems ViroSeq HIV-1 Genotyping System for Sequence-Based Analysis of Non-Subtype B HIV-1 from Uganda. J Clin Microbiol. 2001, 39: 4323-7
Msamanga GI, Taha TE, Young AM, Brown ER, Hoffman IF, Read JS, Mudenda V, Goldenberg RL, Sharma U, Sinkala M, Fawzi WW . Placental malaria and mother-to-child transmission of human immunodeficiency virus-1. Am J Trop Med Hyg. 2009, 80: 508-15, No PMCID http://www.ajtmh.org/content/80/4/508.long
Mugerwa R, Kaleebu P, Mugyenyi P, Katongole-Mbidde E, Hom D, George K, Kebba A, Johnson JL, Schmidt C, Sempala SD, Kityo C, Byaruhanga R, Mugisha E, Flores J, Sheppard CH, Cao H, Othieno C, Allen M, Salata RA, Ellner J for the HIVNET 007 Protocol Team . First trial of the HIV-1 vaccine in Africa: Ugandan experience. BMJ. 2002, 324: 226-9
Musoke P, Guay LA, Bagenda D, Mirochnick M, Nakabiito C, Fleming T, Elliott T, Horton S, Dransfield K, Pav JW, Murarka A, Allen M, Fowler MG, Mofenson L, Hom D, Mmiro F, Jackson JB . A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS. 1999, 13: 479-86
Musoke PM, Young AM, Owor MA, Lubega IR, Brown ER, Mmiro FA, Mofenson LM, Jackson JB, Fowler MG, Guay LA . Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children. J Acquir Immune Defic Syndr. 2008, 49: 171-8. PMCID:2721476
Mwinga K, Vermund SH, Chen YQ, Mwatha A, Read JS, Urassa W, Carpenetti N, Valentine M, Goldenberg RL . Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol. BMC Pedatr. 2009, 7: 49 PMCID: 2746190
Myron S. Cohen, Lawrence Corey, Cohen MS, Corey L . Broadly neutralizing antibodies to prevent HIV-1. Science. 2017, 358: 46-47
Naranbhai V, Moodley D, Chipato T, Stranix-Chibanda L, Nakabaiito C, Kamateeka M, Musoke P, Manji K, George K, Emel LM, Richardson P, Andrew P, Fowler M, Fletcher H, McShane H, Coovadia HM, Hill AV; HPTN 046 Protocol Team . The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum women.. Journal of Acquired Immune Deficiency Syndromes. 2014, 67: 573-5
Ndovi TT, Cao YJ, Fuchs E, Fletcher CV, Guidos A, Hendrix CW . Food affects Zidovudine concentration independent of effects on gastrointestinal absorption. J Clin Pharmacol. 2007, 47: 1366-73
Ndovi TT, Choi L, Caffo B, Parsons T, Baker S, Zhao M, Rohde C, Hendrix CW . Quantitative assessment of seminal vesicle and prostate drug concentrations by use of a noninvasive method. Clin Pharmacol Ther. 2006, 80: 146-58 PMID: 16890576
Neal JD, Tobian AA, Laeyendecker O, Ngo TD, Redd AD, Reynolds SJ, Ashley Morrow R, Manucci JL, Serwadda D, Gray RH, Quinn TC . Performance of the Euroline Western blot assay in the detection of herpes simplex virus type 2 antibody in Uganda, China and the USA. Intl J STD and AIDS. 2011, 22: 342-344 PMCID: 3198953
Nelson LE, Wilton L, Moineddin R, Zhang N, Siddiqi A, Sa T, Harawa N, Regan R, Dyer TP, Watson CC, Koblin B, Del Rio C, Buchbinder S, Wheeler DP, Mayer KH; HPTN 061 Study Team, Mayer KH, HPTN 061 Study Team . Economic, Legal, and Social Hardships Associated with HIV Risk among Black Men who have Sex with Men in Six US Cities. J Urban Health. 2016, 93: 170-88
Nelson LE, Wilton L, Zhang N, Regan R, Thach CT, Dyer TV, Kushwaha S, Sanders RE 2nd, Ndoye O, Mayer KH, HPTN 061 Study Team . Childhood Exposure to Religions With High Prevalence of Members Who Discourage Homosexuality Is Associated With Adult HIV Risk Behaviors and HIV Infection in Black Men Who Have Sex With Men. Am J Mens Health.
Ng OT, Laeyendecker O, Redd AD, Munshaw S, Grabowski MK, Pacquet AC, Evans MC, Haddad M, Huang W, Robb ML, Reynolds S, Gray RH, Wawer MJ, Serwadda D, Eshleman SH, Quinn TC . HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression. J Infect Dis. 2014, 209: 66-73
Ngo TD, Laeyendecker O, Morrow RA, Lai S, Quinn TC . Comparison of three commercial immunoassays for detection of herpes simplex virus type 2 antibodies in commercial sex workers in Yunnan Province, China. Clin Vaccine Immunol. 2008, 15: 1301-3 PMCID: 2519307
Nguyen NL, Powers KA, Hughes JP, MacPhail CL, Piwowar-Manning E, Patel EU, Gomez-Olive FX, Kahn K, Pettifor AE . Sexual Partnership Patterns Among South African Adolescent Girls Enrolled in STI Preventions Trial Network 068: Measurement Challenges and Implications for HIV/STI Transmission. Sex Transm Dis. 2015, 42: 612-8
Ojeda VD, Amico KR, Hughes JP, Wilson E, Holtz TH, Chitwarakorn A, Grant RM, Dye BJ, Bekker L-G, Mannheimer S, Marzinke M, Hendrix CW . Associations Between Research Staff-Participant Interactions and HIV PrEP Adherence in HPTN 067.
Ojikutu BO, Pathak S, Srithanaviboonchai K, Limbada M, Friedman R, Li S, Mimiaga MJ, Mayer KH, Safren SA, HPTN 063 Team . Community Cultural Norms, Stigma and Disclosure to Sexual Partners among Women Living with HIV in Thailand, Brazil and Zambia (HPTN 063). PLoS One. 2016, 11: e0153600
Onyango-Makumbi C, Bagenda D, Mwatha A, Omer SB, Musoke P, Mmiro F, Zwerski SL, Kateera BA, Musisi M, Fowler MG, Jackson JB, Guay LA . Early Weaning of HIV-Exposed Uninfected Infants and Risk of Serious Gastroenteritis: Findings from Two Perinatal HIV Prevention Trials in Kampala, Uganda. J Acquir Immune Defic Syndr. 2010, 53: 20-27 PMCID: 2888913
Palumbo PJ, Wilson EA, Piwowar-Manning E, McCauley M, Gamble T, Kumwenda N, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim JG, Hosseinipour MC, Melo MG, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Chen YQ, Cohen MS, Eshleman SH, Fogel JM . Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052. PLoS One. 2017, 12: e0177281
Palumbo, P. J., Fogel, J. M., Hudelson, S. E., Wilson, E. A., Hart, S., Hovind, L., Piwowar-Manning, E., Wallis, C., Papathanasopoulos, M. A., Morgado, M. G., Saravanan, S., Tripathy, S., Eron, J. J., Gallant, J. E., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Pilotto, J. H., Kumwenda, J., Akelo, V., Godbole, S. V., Santos, B. R., Grinsztejn, B., Panchia, R., Caballero, A., Makhema, J., Badal-Faesen, S., Chen, Y. Q., Cohen, M. S., Eshleman, S. H. . HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052. J Acquir Immune Defic Syndr. 2018, 77: 484-491
Paranjape RS, Gadkari DA, Lubaki M, Quinn TC, Bollinger RC . Cross-reactive HIV-1 Specific CTL in Recent Seroconverters from Pune, India. IJMR. 1998, 108: 35-41
Patel EU, Cox AL, Mehta SH, Boon D, Mullis CE, Astemborski J, Osburn WO, Quinn J, Redd AD, Kirk GD, Thomas DL, Quinn TC, Laeyendecker O . Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection. J Infect Dis.
Patel EU, Manucci J, Kahle EM, Lingappa JR, Morrow RA, Piwowar-Manning E, James A, Maluzi KF, Cheeba MM, Gray G, Delany-Moretlwe S, Inambao M, Vwalika B, Quinn TC, Laeyendecker O . Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment. BMC Infect Dis. 2015, 15: 398
Pauk J, Huang M, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L . Mucosal shedding of human herpesvirus 8 in men. N Engl J Med. 2000, 343: 1369-78
Pechansky F, von Diemen L, Kessler F, Hirakata V, Metzger D, Woody GE . Preliminary estimates of human immunodeficiency virus prevalence and incidence among cocaine abusers of Porto Alegre, Brazil. J Urban Health. 2003, 80: 115-25
Pequegnat W, Fishbein M, Celentano D, Ehrhardt A, Garnett G, Holtgrave D, Jaccard J, Schachter J, Zenilman J . NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. Sex Transm Dis. 2000, 27: 127-32
Pettifor A, Bekker L-G . Adolescent enrollment in HIV prevention trials. Lancet. 2012, 380: 646
Pettifor A, Bekker LG, Hosek S, DiClemente R, Rosenberg M, Bull SS, Allison S, Delany-Moretlwe S, Kapogiannis BG, Cowan F; HIV Prevention Trials Network (HPTN) Adolescent Scientific Committee . Preventing HIV among young people: research priorities for the future. J Acquir Immune Defic Syndr. 2013, 63: S155-60 PMCID: 3746811
Pettifor A, Corneli A, Kamanga G, McKenna K, Rosenberg NE, et al., Yu X, Ou SS, Massa C, Wiyo P, Lynn D, Tharaldson J, Golin C, Hoffman I, HPTN 062 Study Protocol Team . HPTN 062: A Pilot Randomized Controlled Trial Exploring the Effect of a Motivational-Interviewing Intervention on Sexual Behavior among Individuals with Acute HIV Infection in Lilongwe, Malawi. PLoS One. 2015, 10: e0124452
Pettifor A, MacPhail C, Hughes JP, Selin A, Wang J, Gomez-Olive FX, Eshleman SH, Wagner RG, Mabuza W, Khoza N, Suchindran C, Mokoena I, Twine R, Andrew P, Townley E, Laeyendecker O, Agyei Y, Tollman S, Kahn K . The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial. Lancet Glob Health. 2016, 4: e978-e988
Pettifor A, MacPhail C, Selin A, Gomez-Olive FX, Rosenberg M, Wagner RG, Mabuza W, Hughes JP, Suchindran C, Piwowar-Manning E, Wang J, Twine R, Daniel T, Andrew P, Laeyendecker O, Agyei Y, Tollman S, Kahn K, HPTN 068 Protocol Team . HPTN 068: A Randomized Control Trial of a Conditional Cash Transfer to Reduce HIV Infection in Young Women in South Africa-Study Design and Baseline Results.. 2016, 20: 1683-82
Pettifor A, Wang J, Selin A, Hughes J, Gómez-Olivé X, Wagner R, MacPhail C, Kahn K, HPTN 068 Study Team . The impact of a cash transfer on young South African women's on mental health: HPTN 068.
Phakathi Z, Van Rooyen H, Fritz K, Richter L . The influence of antiretroviral treatment on willingness to test: a qualitative study in rural KwaZulu-Natal, South Africa. African Journal of AIDS Research. 2011, 10: 173-80
Ping LH, Jabara CB, Rodrigo AG, Hudelson SE, Piwowar-Manning E, Wang L, Eshleman SH, Cohen MS, Swanstrom R . HIV-1 transmission during early antiretroviral therapy: evaluation of two HIV-1 transmission events in the HPTN 052 prevention study. PLoS One. 2013, 8: e71557
Piwowar-Manning E, Fiamma A, Laeyendecker O, Kulich M, Donnell D, Szekeres G, Robins-Morris L, Mullis CE, Vallari A, Hackett J Jr, Mastro TD, Gray G, Richter L, Alexandre MW, Chariyalertsak S, Chingono A, Sweat M, Coates T, Eshleman SH . HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043). BMC Infect Dis. 2011, 11: 251 PMCID: 3198953
Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke M, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J, Jr., Mannheimer S, del Rio C, Kuo I, Harawa NT, Koblin BA, Moore R, Blankson JN, Eshleman SH . Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening. HIV Clin Trials. 2014, 15: 62-8
Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH . Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa. J Clin Virol. 2015, 62: 75-9
Piwowar-Manning E, Lugalia L, Kafufu B, Jackson JB . Comparison of results obtained with Amplicor HIV-1 DNA PCR test version 1.5 using 100 versus 500 microliters of whole blood. J Clin Microbiol. 2008, 46: 1104-5 PMCID: 2268375
Piwowar-Manning EM, Tustin NB, Sikateyo P, Kamwendo D, Chipungu C, Maharaj R, Mushanyu J, Richardson BA, Hillier S and Jackson JB . Validation of rapid HIV antibody tests in 5 African Countries. J Int Assoc Physicians in AIDS Care. J Int Assoc Physicians AIDS Care. 2010, 9: 170-2 PMCID: 2989535
Potter D, Goldenberg RL, Chao A, Sinkala M, Degroot A, Stringer JS, Bulterys M, Vermund SH . Do targeted HIV programs improve overall care for pregnant women?: Antenatal syphilis management in Zambia before and after implementation of prevention of mother-to-child HIV transmission programs. J Acquir Immune Defic Syndr. 2008, 47: 79-85 PMCID: 2745056
Potter D, Goldenberg RL, Read JS, Wang J, Hoffman IF, Saathoff E, Kafulafula G, Aboud S, Martinson FE, Dahab M, Vermund SH . Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia. Sex Transm Dis. 2006, 33: 604-9 PMCID: 2743105
Price J, Pettifor A, Selin A, Wagner RG, MacPhail C, Agyei Y, Gomez-Olive FX, Kahn K . The association between perceived household educational support and HIV risk in young women in a rural South African community (HPTN 068): A cross sectional study. PLoS One. , 14: e0210632
Pruenglampoo B, Ruangyuttikarn C . Thai clinical research coordinator's journey in HIV/AIDS research. Research Practitioner. 2006, 7: 217-18
Rademeyer C, Moore PL, Taylor N, Martin DP, Choge IA, Gray ES, Sheppard HW, Gray C, Morris L, Williamson C; HIVNET 028 study team . Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies. Virology. 2007, 368: 172-81 PMID:17632196
Ramjee G, Kapiga S, Weiss S, Peterson L, Leburg C, Kelly C, Masse B; the HPTN 055 Study Team . The Value of Site Preparedness Studies for Future Implementation of Phase 2/IIb/III HIV Prevention Trials: Experience From the HPTN 055 Study. JAIDS. 2008, 47: 93-100.